41
1
1
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T73834 | NS5A-IN-2 | HCV Protease | Microbiology/Virology; Proteases/Proteasome |
NS5A-IN-2 (Compound 33)为一种高效的NS5A抑制剂,对HCV基因型1b展现出极高效力,并对基因型3a (GT 3a) 亦具备增强活性与良好的代谢稳定性。 | |||
T74403 |
NS5A-IN-1
|
Others | Others |
NS5A-IN-1 是一种丙型肝炎病毒NS5A 抑制剂 Pibrentasvir(ABT-530)的前体。 | |||
T73223 | NS5A-IN-3 | HCV Protease | Microbiology/Virology; Proteases/Proteasome |
NS5A-IN-3 (Compound 15) 为高效NS5A抑制剂,对HCV基因型1b显示出高效力,并对基因型3a (GT 3a) 活性提升以及展现出良好的代谢稳定性。NS5A-IN-3相较于daclatasvir,对基因型1b具有更高的耐药门槛。 | |||
T74495 |
NS5A-IN-4
|
Others | Others |
NS5A-IN-4 (Compound 1.12) 是一种具有口服活性的泛基因型丙型肝炎病毒 (HCV)NS5A 抑制剂,对gT1b、gT1a、gT2a、gT3a,gT4a 和gT5a 的IC50分别为 1.2、2296、4.6、362、10.3 和 693 pM。 | |||
T11541 |
HCV-IN-30
|
Others; HCV Protease | Microbiology/Virology; Others; Proteases/Proteasome |
HCV-IN-30 是 HCV NS5A 复制复合物的抑制剂(基因型 1a 和 1b 复制子的 IC50 = 901 和 102 nM)。 | |||
T9567 |
Samatasvir
ATOLIHZIXHZSBA-BTSKBWHGSA-N,IDX719 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Samatasvir (ATOLIHZIXHZSBA-BTSKBWHGSA-N) 是 NS5A HCV 复制抑制剂。它能够有效的选择复制子及感染性 HCV,在基因型 1至5 复制子中,EC50= 2~24 pM。 | |||
T25268L |
Coblopasvir dihydrochloride
Coblopasvir dihydrochloride(1312608-46-0 Free base) |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Coblopasvir dihydrochloride 是一种泛基因型非结构蛋白 5A(NS5A)抑制剂。本品可用于慢性丙型肝炎病毒感染的研究。 | |||
T6229 |
Daclatasvir
Daklinza,达卡他韦,EBP 883,达拉他韦,BMS-790052 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Daclatasvir (EBP 883) 是一种高度选择性的 HCV NS5A 抑制剂,EC50 为 9-50 pM,适用于细胞培养中的多种 HCV 复制子基因型和 JFH-1 基因型 2a 感染性病毒。 | |||
T1786 |
Daclatasvir dihydrochloride
BMS-790052 dihydrochloride,盐酸达拉他韦 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) 是有机阴离子转运多肽 1B(OATP1B) 和 OATP1B3抑制剂,IC50分别为 1.5 µM 和 3.27 µM。它也具有口服活性的 HCV NS5A 蛋白抑制剂,多种 HCV 复制子基因型的 EC50范围为 9-146 pM。 | |||
T25268 |
Coblopasvir
|
Others | Others |
Coblopasvir 是一种泛基因型非结构蛋白5A(NS5A)抑制剂。它可以用于研究慢性丙型肝炎病毒的感染。 | |||
T5127 |
ABT530
ABT 530,ABT-530,哌仑他韦,Pibrentasvir |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
ABT530 (Pibrentasvir) 是一种 HCV NS5A 抑制剂,针对含有 NS5A 基因型 1-6 的 HCV 复制子,EC50 范围为 1.4-5.0 pM。 | |||
T6200 |
Ledipasvir
GS-5885,雷迪帕韦 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Ledipasvir (GS-5885) 是一种丙型肝炎病毒 NS5A 抑制剂。它也是 P-糖蛋白抑制剂和乳腺癌抗性蛋白抑制剂。 | |||
T4544 |
Elbasvir
MK-8742 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Elbasvir (MK-8742) 是丙型肝炎病毒的非结构蛋白 5A 抑制剂,可用于治疗慢性 HCV 感染。 | |||
T68015 |
Ruzasvir
MK8408,MK-8408,MK 8408 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Ruzasvir (MK-8408) 是一种新型有效的丙型肝炎病毒NS5A的泛基因型抑制剂,具有抗病毒活性。 | |||
T10493 |
Beclabuvir
BMS-791325 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Beclabuvir (BMS-791325) 是一种高效的 NS5A 复制复合物抑制剂,抑制 HCV 基因型 1,2,4,5 表达的 NS5B 蛋白活性,可用于研究 HCV 感染。 | |||
T4203 |
Ledipasvir (acetone)
Ledipasvir acetone,雷迪帕韦单丙酮溶剂化物,GS-5885 acetone,雷迪帕韦单丙酮 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Ledipasvir (acetone) (GS-5885 acetone) 是 Ledipasvir 的活性药物成分。Ledipasvir 是一种 HCV NS5A 聚合酶抑制剂,用于治疗丙型肝炎病毒感染。 | |||
T24480 |
MK-8325
MK 8325,MK8325 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
MK-8325是一种有效且可口服的HCV NS5A 抑制剂,对多种基因型具有复制活性。MK-8325在体外和体内试验显示生物利用度且具有良好的总体ADME 特征。 | |||
T3334 |
Velpatasvir
GS-5816,维帕他韦 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Velpatasvir (GS-5816) 是一种的 HCV NS5A 抑制剂。它也是 SARS-CoV 3CLpro 的抑制剂,IC50为 2.16 μM。 | |||
T7158 |
Ombitasvir
奥比他韦,ABT-267 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Ombitasvir (ABT-267) 是丙型肝炎病毒非结构蛋白 5A 的口服生物可利用的强效抑制剂。对 HCV 基因型 1 至 5 的 EC50 为 0.82 至 19.3 pM,对基因型 6a 的 EC50 为 366 pM。 | |||
T11548L |
HCV-IN-7 hydrochloride
|
Others | Others |
HCV-IN-7 hydrochloride is an orally active and potent pan-genotypic HCV NS5A inhibitor (IC50s: 3-47 pM). It shows a superior pan-genotypic profile and a good pharmacokinetic profile coupled with a favorable liver uptake. | |||
T11548 |
HCV-IN-7
|
Others | Others |
HCV-IN-7 is an orally active and potent pan-genotypic HCV NS5A inhibitor (IC50s: 3-47 pM). It shows a superior pan-genotypic profile and a good pharmacokinetic profile coupled with a favorable liver uptake. | |||
T30262 |
AZD-7295
A 831,A-831,AZD7295,A831 |
Others | Others |
AZD-7295 (A-689) is an NS5A inhibitor that may be used to treat HCV infection. | |||
T24475 |
MK-4882
MK 4882,MK4882 |
Others | Others |
MK-4882 is an effective inhibitor of HCV NS5A. | |||
T70731 |
Odalasvir
|
Others | Others |
Odalasvir is a novel NS5A inhibitor for the treatment of hepatitis C. | |||
T27461 |
GSK2336805
GSK 2336805,GSK-2336805,JNJ-56914845,GSK-805,GSK805 |
Others | Others |
GSK-2336805 is a HCV NS5A inhibitor. GSK2336805 retained activity on chimeric replicons containing NS5A patient sequences from genotype 1 and patient and consensus sequences for genotypes 4 and 5 and part of genotype 6. | |||
T38858 |
GSK2818713
|
Others | Others |
GSK2818713 is a novel Hepatitis C NS5A replication complex inhibitor. | |||
T71964 |
Ravidasvir HCl
|
Others | Others |
Ravidasvir, also known as PPI-668 and ASC16, is a second-generation, orally active, potent and selective HCV NS5A protein inhibitor. | |||
T11832 |
Ledipasvir D-tartrate
GS-5885 D-tartrate,雷迪帕韦 D-酒石酸 |
Others | Others |
Ledipasvir D-tartrate with EC50 values of 34 pM against GT1a and 4 pM against GT1b replicon. is an inhibitor of the hepatitis C virus NS5A. | |||
T74589 |
Yimitasvir
|
Others | Others |
Yimitasvir (Emitasvir) 是一种口服活性丙肝病毒 (HCV) 非结构蛋白 5A (NS5A) 抑制剂,用于慢性丙型肝炎病毒感染研究。 | |||
T78669 |
(1R,4S)-Yimitasvir diphosphate
(1R,4S)-DAG-181 diphosphate,(1R,4S)-Emitasvir diphosphate |
Others | Others |
Yimitasvir (Emitasvir) diphosphate是一口服活性HCV NS5A抑制剂,适用于研究慢性丙型肝炎病毒感染。 | |||
T37915 |
Monodes(N-carboxymethyl)valine Daclatasvir
|
Others | Others |
Monodes(N-carboxymethyl)valine Daclatasvir, also known as Daclatasvir Impurity A, is the principal degradation product of Daclatasvir.Daclatasvir is a potent inhibitor of the HCV NS5A protein[1]. | |||
T74007 |
Daclatasvir Impurity C
|
Others | Others |
Daclatasvir Impurity C 是 Daclatasvir 的一种杂质。Daclatasvir 是一种有效的 HCVNS5A 蛋白抑制剂。 | |||
T24476 |
MK-6169
MK6169 |
Others | Others |
MK-6169 is an effective Pan-Genotype Hepatitis C Virus NS5A inhibitor. It also has Optimized Activity against Common Resistance-Associated Substitutions. | |||
T74588 |
Yimitasvir diphosphate
|
Others | Others |
Yimitasvir (Emitasvir) diphosphate,一种针对丙型肝炎病毒(HCV)非结构蛋白5A (NS5A)的口服活性抑制剂,适用于慢性丙型肝炎病毒感染的研究。 | |||
T74006 |
Daclatasvir Impurity B
|
Others | Others |
Daclatasvir Impurity B为Daclatasvir杂质之一,后者为一种高效的HCV NS5A蛋白抑制剂。 | |||
T27125 |
DBPR-110
MB110,MB 110,MB-110 |
Others | Others |
DBPR-110 is a nonstructural protein 5A (NS5A) inhibitor. DBPR-110 reduced the reporter expression of the HCV1b replicon with a EC(50) and a selective index value of 3.9 ± 0.9 pM and >12,800,000, respectively. DBPR-110 reduced HCV2a replicon activity with | |||
T76524 |
Hepatitis C Virus S5A/5B
|
||
Hepatitis C Virus S5A/5B是一种合成肽底物,模拟非结构蛋白(NS)的NS5A/5B连接,用于研究HCVNS3蛋白酶活性。 | |||
T71085 |
BMS-824
|
Others | Others |
BMS-824 is a potent NS5A inhibitor. The 50% inhibition of HCV replicon replication for BMS-824 was approximately 5 nM, with a therapeutic index of >10,000. BMS-824 showed good specificity for HCV, as it was not active against several other RNA and DNA viruses. | |||
TP1468 |
HCV-IN-4
|
||
HCV-IN-4, a potent and orally active inhibitor of HCV NS5A, demonstrates significant efficacy against genotypes GT1a, GT2b, GT3a, and the GT1a mutations Y93H and L31V. Its half-maximal effective concentrations (EC90s) are 3 pM, 0.3 nM, 0.01 nM, 0.5 nM, and 0.02 nM, respectively[1]. | |||
T75241 |
Ledipasvir hydrochloride
GS-5885 hydrochloride |
Others | Others |
Ledipasvir (GS-5885) hydrochloride 是抗HCV NS5A 的高效抑制剂,对GT1a 和 GT1b 复制子抑制作用显著,其EC50值仅为34 pM 和 4 pM。此外,Ledipasvir hydrochloride 还能抑制 SARS-CoV 3CLpro, IC50 为1.62 μM。 | |||
T63090 |
SMCypI C31
|
Others | Others |
SMCypIC31 是一种非肽类 cyclophilin 抑制剂,能够有效抑制肽基-脯氨酰顺/反异构酶 (PPIase) (IC50: 0.1 μM)。SMCypI C31 可以破坏亲环蛋白 A-NS5A 相互作用。SMCypI C31 具有泛基因型抗 HCV 效果,对基因型 1a,1b,2a,3a 和 5a HCV-SGRs 和嵌合基因型 2a/4a HCV-SGRs 的 EC50 范围为 1.20-7.76 μM。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN3809 |
Dehydrojuncusol
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is active against resistant HCV variants frequently found in patients with treatment failure. |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-00323 |
Hepatitis C virus (HCV-1a) NS3 protease/helicase immunodominant region Protein (aa 1356-1459, GST)
NS3 |
HCV | E. coli |
HCV NS3 displays three enzymatic activities: serine protease, NTPase, and RNA helicase. HCV NS3 serine protease, in association with NS4A, is responsible for the cleavages of NS3-NS4A, NS4A-NS4B, NS4B-NS5A, and NS5A-NS5B. HCV NS3 RNA helicase binds to RNA and unwinds dsRNA in the 3' to 5' direction, and likely RNA stable secondary structure in the template strand (By similarity). Cleaves and inhibits the host antiviral protein MAVS. NS3/NS4A complex also prevents phosphorylation of human IRF3, t... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TMIH-0297 |
Ledipasvir-d6
|
||
Ledipasvir-d6 是 Ledipasvir 的氘代化合物。Ledipasvir 的 CAS 号为 1256388-51-8。Ledipasvir 是一种丙型肝炎病毒 NS5A 抑制剂。它也是 P-糖蛋白抑制剂和乳腺癌抗性蛋白抑制剂。 |